Cargando…

Different situations of identifying second primary malignant tumors in lymphoma patients with synchronous solid tumors

BACKGROUND: To our knowledge, the different situations of identifying second primary malignant tumors (SPMTs) in lymphoma patients with synchronous solid tumors remain to be comprehensively investigated. METHODS: We retrospectively collected information pertaining to lymphoma patients with synchrono...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Hongye, Wang, Xiaogan, Lai, Yumei, Zhang, Chen, Mi, Lan, Ji, Xinqiang, Wang, Xiaopei, Song, Yuqin, Zhu, Jun, Liu, Weiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134266/ https://www.ncbi.nlm.nih.gov/pubmed/36621802 http://dx.doi.org/10.1002/cam4.5592

Ejemplares similares

Conditional survival and hazards of death for peripheral T-cell lymphomas
por: Gao, Hongye, et al.
Publicado: (2021)

Effect of autologous hematopoietic stem cell transplantation for patients with peripheral T-cell lymphoma in China: A propensity score-matched analysis
por: Gao, Hongye, et al.
Publicado: (2022)

ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma
por: Liu, Yalu, et al.
Publicado: (2019)

A Comparison of Clinical Prognostic Indices in Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with a Pegylated Liposomal Doxorubicin Combination Regimen in China
por: Gao, Hongye, et al.
Publicado: (2022)

Thirty-Two Case Reports of Synchronous Hematological Malignancy and Solid Tumor
por: Liu, Sha, et al.
Publicado: (2019)

The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma
por: Shi, Cunzhen, et al.
Publicado: (2018)

Addition of BTK inhibitor orelabrutinib to rituximab improved anti-tumor effects in B cell lymphoma
por: Yu, Hui, et al.
Publicado: (2021)

Five Cases Report of Solid Tumor Synchronously with Hematologic Malignancy
por: Cui, Yuehong, et al.
Publicado: (2012)

The Clonal Diversity of Peripheral B Cell Receptor Immune Repertoire Impaired by Residual Malignant B Cells Predicts Treatment Efficacy in B Cell Lymphoma Patients
por: Wu, Meng, et al.
Publicado: (2022)

Combination of Enzastaurin and Ibrutinib synergistically induces anti-tumor effects in diffuse large B cell lymphoma
por: He, Yizi, et al.
Publicado: (2019)

Correlation between lymphoma and second primary malignant tumor
por: Liu, Lingjuan, et al.
Publicado: (2023)

Synchronous multiple primary tumors in patients with malignant lymphoma: a retrospective study
por: Yagi, Yu, et al.
Publicado: (2022)

Burden of lymphoma in China, 2006–2016: an analysis of the Global Burden of Disease Study 2016
por: Liu, Weiping, et al.
Publicado: (2019)

Single or tandem autologous stem cell transplantation for treating Chinese patients with refractory/relapsed classical Hodgkin lymphoma
por: Zhang, Chen, et al.
Publicado: (2023)

Multiple primary synchronous malignant tumors
por: Testori, Alberto, et al.
Publicado: (2015)

Burden of lymphoma in China, 1990−2019: an analysis of the global burden of diseases, injuries, and risk factors study 2019
por: Liu, Weiping, et al.
Publicado: (2022)

Second primary malignancy among malignant solid tumor survivors aged 85 years and older
por: Zhang, Zhijia, et al.
Publicado: (2021)

Clinical and genetic characteristics in lymphoma patients with a second solid malignancy
por: Zhou, Di, et al.
Publicado: (2023)

EP300 single nucleotide polymorphism rs20551 correlates with prolonged overall survival in diffuse large B cell lymphoma patients treated with R-CHOP
por: Li, Jiao, et al.
Publicado: (2017)

Synchronous Double Malignant Tumors Consisting of Stomach and Hodgkin's Lymphoma with Collision between Gastric Adenocarcinoma and Hodgkin's Lymphoma in the Stomach
por: Yanagawa, Naoki, et al.
Publicado: (2012)

Effect of infection with hepatitis B virus on the survival outcome of diffuse large B-cell lymphoma in the prophylactic antiviral era
por: Nuersulitan, Reyizha, et al.
Publicado: (2022)

Mortality of lymphoma and myeloma in China, 2004–2017: an observational study
por: Liu, Weiping, et al.
Publicado: (2019)

TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP
por: Liu, Yalu, et al.
Publicado: (2017)

Unusual Synchronous Association of Solid Tumors with Hematological Malignancies in Multiple Primary Cancers: Case Series and Literature Review
por: Al-Gahmi, Aboelkhair, et al.
Publicado: (2021)

PB2359: SYNCHRONOUS SOLID TUMORS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES: EXPERIENCE IN A PUBLIC HEALTHY SYSTEM IN BRAZIL.
por: Teixeira, Larissa, et al.
Publicado: (2023)

The Serum- and Glucocorticoid-Inducible Kinase 1 (SGK1) as a Novel Therapeutic Target in Mantle Cell Lymphoma
por: Li, Jiao, et al.
Publicado: (2022)

Synchronous Malignant Phyllodes Tumor with Skin Ulceration and Invasive Carcinoma as Collision Tumor
por: Muthusamy, Rajeshwari K, et al.
Publicado: (2017)

Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors
por: Lv, Meng, et al.
Publicado: (2017)

Survival and prognostic analysis of T-cell lymphoblastic lymphoma patients treated with dose-adjusted BFM-90 regimen
por: Yu, Hui, et al.
Publicado: (2022)

Squamous Esophageal Carcinoma Synchronous to Pericolic Malignant Conjunctive Tumor
por: VASILE, MANUELA IOANA, et al.
Publicado: (2017)

Two synchronous malignant tumors of the pancreas: a case report
por: De Silva, W. S. L., et al.
Publicado: (2017)

Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases
por: Yu, Youxi, et al.
Publicado: (2022)

P1287: HETROMBOPAG FOR ENHANCEMENT OF PLATELET ENGRAFTMENT IN PATIENTS WITH LYMPHOMA AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Zhao, Linjun, et al.
Publicado: (2023)

ALK Negative Inflammatory Myofibroblastic Tumor Synchronous with Classical Hodgkin Lymphoma
por: Sandoval, Letícia, et al.
Publicado: (2019)

Screening for synchronous esophageal second primary tumors in patients with head and neck cancer
por: van de Ven, Steffi E M, et al.
Publicado: (2021)

Second primary malignancies after treatment for malignant lymphoma
por: Okines, A, et al.
Publicado: (2005)

Pattern of malignant solid tumors and lymphomas in children in the east delta of Egypt: A five-year study
por: HESHAM, MERVAT, et al.
Publicado: (2014)

Evaluation of IL-2 and Dexamethasone intracavitary injection on the management of malignant effusion in children with solid tumors or lymphoma
por: Zhang, Yu-Tong, et al.
Publicado: (2021)

Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades
por: Liu, Weiping, et al.
Publicado: (2020)

Synchronously diagnosed lymph nodal collision tumor of malignant melanoma and chonic lymphocytic leukemia/small lymphocytic lymphoma: case report
por: El Demellawy, Dina, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_g8pbgqtd5lp2kjglsk2hvem0u6